glp-1 news today 2025 november 6 New oral drug delivers up to 12% weight loss in 36 weeks The Trump Administration is delivering

What appealed to you about transitioning to industry

Both injectable and nasal spray forms are used in practice, with the choice often depending on patient preference, treatment adherence, and desired intensity of effect

As in the case of paracetamol overdose, this type of injury occurs shortly after some threshold for toxicity is reached

In a Phase 3 head-to-head trial, the company compared CagriSemas performance with that of Lillys tirzepatide, which is known to achieve greater weight loss than semaglutide

Strong medical expertise and pharmaceutical innovation capabilities are supporting the adoption of cutting-edge GLP-1 technologies among healthcare providers prioritizing treatment quality and patient outcomes excellence in diabetes care applications